Gene · 3145
Papers3,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide transcriptional profiling and physiological investigation elucidating the molecular mechanism of multiple abiotic stress response in Stevia rebaudiana Bertoni. | Sci Rep | 2023 | 37963906 | PubTator, text mining | PubMed |
| Identification of a Complex Karyotype Signature with Clinical Implications in AML and MDS-EB Using Gene Expression Profiling. | Cancers (Basel) | 2023 | 37958462 | PubTator, text mining | PubMed |
| Construction of iron metabolism-related prognostic features of gastric cancer based on RNA sequencing and TCGA database. | BMC Cancer | 2023 | 37957566 | PubTator, text mining | PubMed |
| Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis. | Front Cell Infect Microbiol | 2023 | 37942479 | PubTator, text mining | PubMed |
| Evaluation of Ex Vivo Adrenocorticotropic Hormone Responsiveness of Human Fetal Testis. | Endocrinology | 2023 | 37935047 | PubTator, text mining | PubMed |
| A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma. | Aging (Albany NY) | 2023 | 37934582 | PubTator, text mining | PubMed |
| A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab. | IJU Case Rep | 2023 | 37928308 | PubTator, text mining | PubMed |
| A novel mutation c.457C > T p.Q153 in the HMBS gene in a Mexican woman with acute intermittent porphyria. | Clin Case Rep | 2023 | 37900716 | PubTator, text mining | PubMed |
| An approach for collaborative development of a federated biomedical knowledge graph-based question-answering system: Question-of-the-Month challenges. | J Clin Transl Sci | 2023 | 37900350 | PubTator, text mining | PubMed |
| Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study. | Genes (Basel) | 2023 | 37895284 | PubTator, text mining | PubMed |
| LRP10, PGK1 and RPLP0: Best Reference Genes in Periprostatic Adipose Tissue under Obesity and Prostate Cancer Conditions. | Int J Mol Sci | 2023 | 37894825 | PubTator, text mining | PubMed |
| An Analysis and Literature Review of a Family Case of Acute Intermittent Porphyria With Initial Symptoms of Epileptic Seizure. | Cureus | 2023 | 37872925 | PubTator, text mining | PubMed |
| Needle in a Haystack: Acute Intermittent Porphyria, an Often-missed Differential Diagnosis of Abdominal Pain. | J Community Hosp Intern Med Perspect | 2023 | 37868674 | PubTator, text mining | PubMed |
| Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma. | PeerJ | 2023 | 37842058 | PubTator, text mining | PubMed |
| Photodynamic therapy and associated targeting methods for treatment of brain cancer. | Front Pharmacol | 2023 | 37841921 | PubTator, text mining | PubMed |
| Genomic Biomarker Discovery in Disease Progression and Therapy Response in Bladder Cancer Utilizing Machine Learning. | Cancers (Basel) | 2023 | 37835496 | PubTator, text mining | PubMed |
| Hepatitis B virus infection disrupts homologous recombination in hepatocellular carcinoma by stabilizing resection inhibitor ADRM1. | J Clin Invest | 2023 | 37815873 | PubTator, text mining | PubMed |
| The application of social recommendation algorithm integrating attention model in movie recommendation. | Sci Rep | 2023 | 37805526 | PubTator, text mining | PubMed |
| Gene editing of SAMHD1 in macrophage-like cells reveals complex relationships between SAMHD1 phospho-regulation, HIV-1 restriction, and cellular dNTP levels. | mBio | 2023 | 37800914 | PubTator, text mining | PubMed |
| HMBS gene mutations and hydroxymethylbilane synthase activity in acute intermittent porphyria: A systematic review. | Medicine (Baltimore) | 2023 | 37773850 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3145/papers?page=11